Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing

International Journal of Vascular Medicine

Volumn 2012, Issue , 2012, Pages

  Kolluru, Gopi Krishna ^a   Bir, Shyamal C ^a   Kevil, Christopher G ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDEHYDE OXIDASE; ALPHA TOCOPHEROL; ANGIOPOIETIN RECEPTOR; ARGINASE; ASCORBIC ACID; DIPYRIDAMOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE OXIDASE; GLUTAREDOXIN; GLYCOPROTEIN GP 91; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXYNITRITE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; RUBOXISTAURIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 1; VASCULOTROPIN A; XANTHINE OXIDASE;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; BIOAVAILABILITY; BRAIN ISCHEMIA; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; DENERVATION; DIABETIC RETINOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GLYCOSYLATION; HEART VENTRICLE REMODELING; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID PEROXIDATION; MACROPHAGE; MONOCYTE; NEUROPROTECTION; NEUTROPHIL; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVASCULARIZATION; REVIEW; STEM CELL MOBILIZATION; THROMBOCYTE AGGREGATION; WOUND HEALING;

EID: 84862182412     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2012/918267     Document Type: Review

References (371)

1. Goligorsky M. S., Endothelial cell dysfunction: can't live with it, how to live without it. American Journal of Physiology 2005 288 5 F871 F880 2-s2.0-17644424936 10.1152/ajprenal.00333.2004 (Pubitemid 40569751)
2. Deanfield J., Donald A., Ferri C., Giannattasio C., Halcox J., Halligan S., Lerman A., Mancia G., Oliver J. J., Pessina A. C., Rizzoni D., Rossi G. P., Salvetti A., Schiffrin E. L., Taddei S., Webb D. J., Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension. Journal of Hypertension 2005 23 1 7 17 2-s2.0-19944430327 10.1097/00004872-200501000-00004 (Pubitemid 40128972)
3. Wild S., Roglic G., Green A., Sicree R., King H., Global Prevalence of Diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
4. Li H., Isomaa B., Taskinen M. R., Groop L., Tuomi T., Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 2000 23 5 589 594 2-s2.0-0034074363 (Pubitemid 30321535)
5. Steinberger J., Daniels S. R., Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American heart association scientific statement from the atherosclerosis, hypertension, and obesity in the young committee (council on cardiovascular disease in the young) and the diabetes committee (council on nutrition, physical activity, and metabolism). Circulation 2003 107 10 1448 1453 2-s2.0-0037453031 10.1161/01.CIR.0000060923.07573.F2 (Pubitemid 36350747)
6. Bir S. C., Esaki J., Marui A., Yamahara K., Tsubota H., Ikeda T., Sakata R., Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. Journal of Vascular Surgery 2009 50 4 870 879 2-s2.0-70349314327 10.1016/j.jvs.2009.06.016
7. Cao R., Bråkenhielm E., Pawliuk R., Wariaro D., Post M. J., Wahlberg E., Leboulch P., Cao Y., Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nature Medicine 2003 9 5 604 613 2-s2.0-0038363443 10.1038/nm848 (Pubitemid 36597108)
8. Martin A., Komada M. R., Sane D. C., Abnormal angiogenesis in diabetes mellitus. Medicinal Research Reviews 2003 23 2 117 145 2-s2.0-0037372172 10.1002/med.10024 (Pubitemid 36241095)
9. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
10. Al-Isa A. N., Thalib L., Akanji A. O., Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 2010 208 2 543 549 2-s2.0-74749100144 10.1016/j.atherosclerosis. 2009.07.056
11. Corrado E., Rizzo M., Coppola G., Muratori I., Carella M., Novo S., Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coronary Artery Disease 2008 19 3 139 144 2-s2.0-42349092222 10.1097/MCA.0b013e3282f3fbde (Pubitemid 351555966)
12. Perticone F., Ceravolo R., Pujia A., Ventura G., Iacopino S., Scozzafava A., Ferraro A., Chello M., Mastroroberto P., Verdecchia P., Schillaci G., Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001 104 2 191 196 2-s2.0-0035838416 (Pubitemid 32655837)
13. Bucala R., Tracey K. J., Cerami A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. The Journal of Clinical Investigation 1991 87 2 432 438 2-s2.0-0026062122
14. Suuronen E. J., Hazra S., Zhang P., Vincent R., Kumarathasan P., Zhang Y., Price J., Chan V., Sellke F. W., Mesana T. G., Veinot J. P., Ruel M., Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia- induced endothelial dysfunction and rescue with l-arginine supplementation. Journal of Thoracic and Cardiovascular Surgery 2010 139 1 209 216 2-s2.0-73149105492 10.1016/j.jtcvs.2009.04.055
15. Kaneto H., Katakami N., Matsuhisa M., Matsuoka T. A., Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators of Inflammation 2010 2010 11 2-s2.0-77952480033 10.1155/2010/453892 453892
16. Witting P. K., Rayner B. S., Wu B. J., Ellis N. A., Stocker R., Hydrogen peroxide promotes endothelial dysfunction by stimulating multiple sources of superoxide anion radical production and decreasing nitric oxide bioavailability. Cellular Physiology and Biochemistry 2007 20 5 255 268 2-s2.0-34548361213 10.1159/000107512 (Pubitemid 47340589)
17. McCance D. R., Hanson R. L., Pettitt D. J., Bennett P. H., Hadden D. R., Knowler W. C., Diagnosing diabetes mellitusdo we need new criteria? Diabetologia 1997 40 3 247 255 2-s2.0-0031019398 10.1007/s001250050671 (Pubitemid 27096547)
18. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M., Childhood vaccination and type 1 diabetes. The New England Journal of Medicine 2004 350 14 1398 1404 2-s2.0-1842483423 10.1056/NEJMoa032665 (Pubitemid 38419993)
19. MacKinnon M., Type 2 diabetes. Nursing Standard 1999 14 10 39 46 2-s2.0-0033601022
20. Carmeliet P., Mechanisms of angiogenesis and arteriogenesis. Nature Medicine 2000 6 4 389 395 2-s2.0-0034076189 10.1038/74651 (Pubitemid 30208155)
21. Carmeliet P., Jain R. K., Angiogenesis in cancer and other diseases. Nature 2000 407 6801 249 257 2-s2.0-0034648765 10.1038/35025220
22. Semenza G. L., Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. Journal of Cellular Biochemistry 2007 102 4 840 847 2-s2.0-35648932996 10.1002/jcb.21523 (Pubitemid 350036924)
23. Wahlberg E., Angiogenesis and arteriogenesis in limb ischemia. Journal of Vascular Surgery 2003 38 1 198 203 2-s2.0-0038108820 10.1016/S0741-5214(03) 00151-4 (Pubitemid 41123313)
24. Helisch A., Schaper W., Arteriogenesis: the development and growth of collateral arteries. Microcirculation 2003 10 1 83 97 2-s2.0-0038043522 10.1038/sj.mn.7800173 (Pubitemid 39004238)
25. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
26. Paravicini T. M., Touyz R. M., NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008 31 S170 S180 2-s2.0-41149150716
27. Kajiya M., Hirota M., Inai Y., Kiyooka T., Morimoto T., Iwasaki T., Endo K., Mohri S., Shimizu J., Yada T., Ogasawara Y., Naruse K., Ohe T., Kajiya F., Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats. American Journal of Physiology 2007 292 6 H2737 H2744 2-s2.0-34447512854 10.1152/ajpheart.00548.2006 (Pubitemid 47084522)
28. Shimokawa H., Matoba T., Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacological Research 2004 49 6 543 549 2-s2.0-1542512315 10.1016/j.phrs.2003.10.016 (Pubitemid 38338664)
29. Tsuji S., Taniuchi S., Hasui M., Yamamoto A., Kobayashi Y., Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 2002 7 4 283 288 2-s2.0-0036435835 10.1016/S1089-8603(02)00110-6 (Pubitemid 35365673)
30. San Martín A., Du P., Dikalova A., Lassègue B., Aleman M., Góngora M. C., Brown K., Joseph G., Harrison D. G., Taylor W. R., Jo H., Griendling K. K., kgriend@emory.edu Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. American Journal of Physiology 2007 292 5 H2073 H2082 10.1152/ajpheart.00943.2006 (Pubitemid 47084581)
31. Pawlak K., Naumnik B., Brzósko S., Pawlak D., Myśliwiec M., Oxidative stressa link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. American Journal of Nephrology 2004 24 1 154 161 2-s2.0-1342344036 10.1159/000076244 (Pubitemid 38250488)
32. Shen G. X., Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. Canadian Journal of Physiology and Pharmacology 2010 88 3 241 248 2-s2.0-77950915621 10.1139/Y10-018
33. Mira L., Maia L., Barreira L., Manso C. F., Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Archives of Biochemistry and Biophysics 1995 318 1 53 58 2-s2.0-0028903713 10.1006/abbi.1995.1203
34. Kundu T. K., Hille R., Velayutham M., Zweier J. L., Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Archives of Biochemistry and Biophysics 2007 460 1 113 121 2-s2.0-33947723940 10.1016/j.abb.2006.12.032 (Pubitemid 46505003)
35. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
36. Badwey J. A., Karnovsky M. L., Production of superoxide and hydrogen peroxide by an NADH oxidase in guinea pig polymorphonuclear leukocytes. Modulation by nucleotides and divalent cations. The Journal of Biological Chemistry 1979 254 22 11530 11537 2-s2.0-0018635817 (Pubitemid 10140081)
37. Bravard A., Bonnard C., Durand A., Chauvin M.-A., Favier R., Vidal H., Rieusset J., jennifer.rieusset@univ-lyon1.fr Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. American Journal of Physiology 2011 300 3 E581 E591 10.1152/ajpendo.00455.2010
38. Matsumoto S., Koshiishi I., Inoguchi T., Nawata H., Utsumi H., Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radical Research 2003 37 7 767 772 2-s2.0-0038476475 10.1080/1071576031000107344 (Pubitemid 36626436)
39. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M. A., Morio B., Vidal H., Rieusset J., Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. The Journal of Clinical Investigation 2008 118 2 789 800 2-s2.0-38849199866 10.1172/JCI32601 (Pubitemid 351206566)
40. Ulrich P., Cerami A., Protein glycation, diabetes, and aging. Recent Progress in Hormone Research 2001 56 1 21 2-s2.0-0035787070 10.1210/rp.56.1.1 (Pubitemid 36068052)
41. Su J., Lucchesi P. A., Gonzalez-Villalobos R. A., Palen D. I., Rezk B. M., Suzuki Y., Boulares H. A., Matrougui K., Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 8 1432 1438 2-s2.0-52449129894 10.1161/ATVBAHA.108.167205
42. Lenaz G., Bovina C., D'Aurelio M., Fato R., Formiggini G., Genova M. L., Giuliano G., Pich M. M., Paolucci U., Castelli G. P., Ventura B., Role of mitochondria in oxidative stress and aging. Annals of the New York Academy of Sciences 2002 959 199 213 2-s2.0-18344366874 (Pubitemid 34457563)
43. Fosslien E., Review: mitochondrial medicinemolecular pathology of defective oxidative phosphorylation. Annals of Clinical and Laboratory Science 2001 31 1 25 67 2-s2.0-0035142151 (Pubitemid 32097212)
44. Abdul-Ghani M. A., Matsuda M., DeFronzo R. A., Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabetic Medicine 2008 25 11 1289 1294 2-s2.0-55149107203 10.1111/j.1464-5491. 2008.02597.x
45. Davidson S. M., Duchen M. R., Endothelial mitochondria: contributing to vascular function and disease. Circulation Research 2007 100 8 1128 1141 2-s2.0-34247598856 10.1161/01.RES.0000261970.18328.1d (Pubitemid 46684126)
46. Nishikawa T., Edelstein D., Du X. L., Yamagishi S. I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
47. Bottino R., Balamurugan A. N., Tse H., Thirunavukkarasu C., Ge X., Profozich J., Milton M., Ziegenfuss A., Trucco M., Piganelli J. D., Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004 53 10 2559 2568 2-s2.0-4644233237 10.2337/diabetes.53.10.2559 (Pubitemid 39299262)
48. Gamble D. R., Taylor K. W., Cumming H., Coxsackie viruses and diabetes mellitus. British Medical Journal 1973 4 5887 260 262 2-s2.0-0015809314
49. Gyurko R., Siqueira C. C., Caldon N., Gao L., Kantarci A., Van Dyke T. E., Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. Journal of Immunology 2006 177 10 7250 7256 2-s2.0-33750808412 (Pubitemid 44715094)
50. Maechler P., Jornot L., Wollheim C. B., Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. The Journal of Biological Chemistry 1999 274 39 27905 27913 2-s2.0-0033600762 10.1074/jbc.274.39.27905 (Pubitemid 29458046)
51. Takasu N., Komiya I., Asawa T., Nagasawa Y., Yamada T., Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets: H2O2 as mediator for DNA fragmentation. Diabetes 1991 40 9 1141 1145 2-s2.0-0025908652
52. Suarez-Pinzon W. L., Szabó C., Rabinovitch A., Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β -cells. Diabetes 1997 46 5 907 911 2-s2.0-0030987135 (Pubitemid 27188272)
53. Lenzen S., Drinkgern J., Tiedge M., Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine 1996 20 3 463 466 2-s2.0-0029984682 10.1016/0891-5849(96)02051-5 (Pubitemid 26077870)
54. Lenzen S., Oxidative stress: the vulnerable β -cell. Biochemical Society Transactions 2008 36 3 343 347 2-s2.0-45249089262 10.1042/BST0360343 (Pubitemid 351839328)
55. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 2002 23 5 599 622 2-s2.0-0036796875 10.1210/er.2001-0039 (Pubitemid 35191625)
56. Poitout V., Robertson R. P., Minireview: secondary β -cell failure in type 2 diabetesa convergence of glucotoxicity and lipotoxicity. Endocrinology 2002 143 2 339 342 2-s2.0-0036153256 10.1210/en.143.2.339 (Pubitemid 34107184)
57. Hirosumi J., Tuncman G., Chang L., Görgün C. Z., Uysal K. T., Maeda K., Karin M., Hotamisligil G. S., A central, role for JNK in obesity and insulin resistance. Nature 2002 420 6913 333 336 2-s2.0-0037153158 10.1038/nature01137 (Pubitemid 35398190)
58. Hotamisligil G. S., Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 2005 54 2 S73 S78 2-s2.0-33644750396 10.2337/diabetes.54.suppl2.S73 (Pubitemid 43343334)
59. Pieper G. M., Gross G. J., Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. American Journal of Physiology 1988 255 4 H825 H833 2-s2.0-0023713429
60. Rösen P., Nawroth P. P., King G., Möller W., Tritschler H. J., Packer L., The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society. Diabetes/Metabolism Research and Reviews 2001 17 3 189 212 2-s2.0-0034939115 10.1002/dmrr.196 (Pubitemid 32624602)
61. Tesfamariam B., Free radicals in diabetic endothelial cell dysfunction. Free Radical Biology and Medicine 1994 16 3 383 391 2-s2.0-0028274304 10.1016/0891-5849(94)90040-X (Pubitemid 24122884)
62. Tirosh A., Potashnik R., Bashan N., Rudich A., Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. The Journal of Biological Chemistry 1999 274 15 10595 10602 2-s2.0-0033537830 10.1074/jbc.274.15.10595 (Pubitemid 29180942)
63. Waeber G., Delplanque J., Bonny C., Mooser V., Steinmann M., Widmann C., Maillard A., Miklossy J., Dina C., Hani E. H., Vionnet N., Nicod P., Boutin P., Froguel P., The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nature Genetics 2000 24 3 291 295 2-s2.0-0034104298 10.1038/73523 (Pubitemid 30132201)
64. West I. C., Radicals and oxidative stress in diabetes. Diabetic Medicine 2000 17 3 171 180 2-s2.0-0033994409 10.1046/j.1464-5491.2000.00259.x (Pubitemid 30212288)
65. Kim Y. K., Lee M. S., Son S. M., Kim I. J., Lee W. S., Rhim B. Y., Hong K. W., Kim C. D., Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 2002 51 2 522 527 2-s2.0-0036062227 (Pubitemid 34764812)
66. Oyama Y., Kawasaki H., Hattori Y., Kanno M., Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. European Journal of Pharmacology 1986 132 1 75 78 2-s2.0-0022828334 (Pubitemid 17229974)
67. Alexander R. W., Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995 25 2 155 161
68. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 4766 4770 2-s2.0-0028363366 10.1073/pnas.91.11.4766 (Pubitemid 24177730)
69. Ebrahimian T. G., Heymes C., You D., Blanc-Brude O., Mees B., Waeckel L., Duriez M., Vilar J., Brandes R. P., Levy B. I., Shah A. M., Silvestre J. S., NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. American Journal of Pathology 2006 169 2 719 728 2-s2.0-33746641678 10.2353/ajpath.2006.060042 (Pubitemid 44156327)
70. Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., Peters K., Isner J. M., Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. American Journal of Pathology 1999 154 2 355 363 2-s2.0-0032965317 (Pubitemid 29094086)
71. Tamarat R., Silvestre J. S., Huijberts M., Benessiano J., Ebrahimian T. G., Duriez M., Wautier M. P., Wautier J. L., Lévy B. I., Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8555 8560 2-s2.0-0038152985 10.1073/pnas. 1236929100 (Pubitemid 36842582)
72. Waltenberger J., Lange J., Kranz A., Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 2000 102 2 185 190 2-s2.0-0034636835 (Pubitemid 30451775)
73. Tepper O. M., Galiano R. D., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P., Gurtner G. C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 22 2781 2786 2-s2.0-0037180517 10.1161/01.CIR.0000039526.42991.93 (Pubitemid 35396976)
74. Deshpande N. N., Sorescu D., Seshiah P., Ushio-Fukai M., Akers M., Yin Q., Griendling K. K., Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxidants and Redox Signaling 2002 4 5 845 854 2-s2.0-0036774407 (Pubitemid 35246948)
75. Griendling K. K., FitzGerald G. A., Oxidative stress and cardiovascular injury: part ii: animal and human studies. Circulation 2003 108 17 2034 2040 2-s2.0-0242349764 10.1161/01.CIR.0000093661.90582.c4 (Pubitemid 37337574)
76. Tojo T., Ushio-Fukai M., Yamaoka-Tojo M., Ikeda S., Patrushev N., Alexander R. W., Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 2005 111 18 2347 2355 2-s2.0-18444401175 10.1161/01.CIR.0000164261.62586.14 (Pubitemid 40647071)
77. Guzik T. J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K. M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002 105 14 1656 1662 2-s2.0-0037046214 10.1161/01.CIR.0000012748.58444.08 (Pubitemid 34298608)
78. Ellis E. A., Guberski D. L., Somogyi-Mann M., Grant M. B., Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/WOR diabetic rat. Free Radical Biology and Medicine 2000 28 1 91 101 2-s2.0-0033621686 10.1016/S0891-5849(99)00216-6 (Pubitemid 30045577)
79. Griendling K. K., Sorescu D., Ushio-Fukai M., NAD(P)H oxidase: role in cardiovascular biology and disease. Circulation Research 2000 86 5 494 501 2-s2.0-0034677947 (Pubitemid 30165039)
80. Sonta T., Inoguchi T., Tsubouchi H., Sekiguchi N., Kobayashi K., Matsumoto S., Utsumi H., Nawata H., Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radical Biology and Medicine 2004 37 1 115 123 2-s2.0-2942562273 10.1016/j.freeradbiomed.2004.04.001 (Pubitemid 38746655)
81. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S. I., Ma Y., Fujimoto M., Quinn M. T., Pagano P. J., Johnson C., Alexander R. W., Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circulation Research 2002 91 12 1160 1167 2-s2.0-0036954803 10.1161/01.RES.0000046227.65158.F8 (Pubitemid 36076365)
82. Al-Shabrawey M., Rojas M., Sanders T., Behzadian A., El-Remessy A., Bartoli M., Parpia A. K., Liou G., Caldwell R. B., Role of NADPH oxidase in retinal vascular inflammation. Investigative Ophthalmology and Visual Science 2008 49 7 3239 3244 2-s2.0-48249134698 10.1167/iovs.08-1755
83. Al-Shabrawey M., Bartoli M., El-Remessy A. B., Ma G., Matragoon S., Lemtalsi T., Caldwell R. W., Caldwell R. B., Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Investigative Ophthalmology and Visual Science 2008 49 7 3231 3238 2-s2.0-48249088030 10.1167/iovs.08-1754
84. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R. A., Warnholtz A., Meinertz T., Griendling K., Harrison D. G., Forstermann U., Munzel T., Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research 2001 88 2 E14 E22 2-s2.0-0035793616
85. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A. M., Dimmeler S., Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nature Medicine 2003 9 11 1370 1376 2-s2.0-0345276632 10.1038/nm948 (Pubitemid 37466185)
86. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
87. Fadini G. P., Agostini C., Sartore S., Avogaro A., Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007 194 1 46 54 2-s2.0-34648841034 10.1016/j.atherosclerosis.2007.03.046 (Pubitemid 47464318)
88. Loomans C. J. M., de Koning E. J. P., Staal F. J. T., Rookmaaker M. B., Verseyden C., De Boer H. C., Verhaar M. C., Braam B., Rabelink T. J., Van Zonneveld A. J., Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004 53 1 195 199 2-s2.0-9144271032 10.2337/diabetes.53.1.195 (Pubitemid 38044715)
89. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z. Y., Yamauchi T., Kuboki K., Meier M., Rhodes C. J., King G. L., Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. The Journal of Clinical Investigation 1999 103 2 185 195 2-s2.0-0032921465 (Pubitemid 29053136)
90. Wohaieb S. A., Godin D. V., Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987 36 9 1014 1018 2-s2.0-0023576328 (Pubitemid 18088387)
91. Aktunc E., Ozacmak V. H., Ozacmak H. S., Barut F., Buyukates M., Kandemir O., Demircan N., N-acetyl cysteine promotes angiogenesis and clearance of free oxygen radicals, thus improving wound healing in an alloxan-induced diabetic mouse model of incisional wound. Clinical and Experimental Dermatology 2010 35 8 902 909 2-s2.0-78149386479 10.1111/j.1365-2230.2010.03823.x
92. Abaci A., Oguzhan A., Kahraman S., Eryol N. K., Ünal S., Arinç H., Ergin A., Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999 99 17 2239 2242 2-s2.0-0032960337 (Pubitemid 29201128)
93. Bohlen H. G., Lash J. M., Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. American Journal of Physiology 1993 265 1 H219 H225 2-s2.0-0027293302 (Pubitemid 23224713)
94. Pieper G. M., Meier D. A., Hager S. R., Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. American Journal of Physiology 1995 269 3 H845 H850 2-s2.0-0029095414
95. Tesfamariam B., Brown M. L., Deykin D., Cohen R. A., Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. The Journal of Clinical Investigation 1990 85 3 929 932 2-s2.0-0025215946 (Pubitemid 20087498)
96. Clarkson P., Celermajer D. S., Donald A. E., Sampson M., Sorensen K. E., Adams M., Yue D. K., Betteridge D. J., Deanfield J. E., Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. Journal of the American College of Cardiology 1996 28 3 573 579 2-s2.0-0030246905 10.1016/S0735-1097(96)0022-8 (Pubitemid 26288635)
97. Johnstone M. T., Creager S. J., Scales K. M., Cusco J. A., Lee B. K., Creager M. A., Impaired endothelium-dependent vasodilation in patients with insulin- dependent diabetes mellitus. Circulation 1993 88 6 2510 2516 2-s2.0-0027381832 (Pubitemid 23360174)
98. Williams S. B., Cusco J. A., Roddy M. A., Johnstone M. T., Creager M. A., Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 1996 27 3 567 574 2-s2.0-0030007350 10.1016/0735-1097(95)00522-6 (Pubitemid 26081917)
99. King G. L., The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Annals of Medicine 1996 28 5 427 432 2-s2.0-0029847340 (Pubitemid 26380002)
100. Rask-Madsen C., King G. L., george.king@joslin.harvard.edu Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nature Clinical Practice Endocrinology and Metabolism 2007 3 1 46 56 10.1038/ncpendmet0366 (Pubitemid 46006612)
101. Tan K. C. B., Chow W. S., Ai V. H. G., Lam K. S. L., Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. Diabetes/Metabolism Research and Reviews 2002 18 1 71 76 2-s2.0-0036200330 10.1002/dmrr.255 (Pubitemid 34257369)
102. Kim J. A., Montagnani M., Kwang K. K., Quon M. J., Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 15 1888 1904 2-s2.0-33646178955 10.1161/CIRCULATIONAHA.105.563213 (Pubitemid 43739401)
103. Tesfamariam B., Brown M. L., Cohen R. A., Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. The Journal of Clinical Investigation 1991 87 5 1643 1648 2-s2.0-0025832494
104. Saenz de Tejada I., Goldstein I., Azadzoi K., Krane R. J., Cohen R. A., Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. The New England Journal of Medicine 1989 320 16 1025 1030 2-s2.0-0024559857 (Pubitemid 19105745)
105. Ting H. H., Timimi F. K., Boles K. S., Creager S. J., Ganz P., Creager M. A., Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. The Journal of Clinical Investigation 1996 97 1 22 28 2-s2.0-0030034465 (Pubitemid 26021690)
106. Pieper G. M., Moore-Hilton G., Roza A. M., Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sciences 1996 58 9 PL147 PL152 2-s2.0-0030058769 10.1016/0024-3205(95)02360-7
107. Du X. L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M., Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. The Journal of Clinical Investigation 2001 108 9 1341 1348 2-s2.0-0035180299 10.1172/JCI200111235 (Pubitemid 33107762)
108. Veves A., Akbari C. M., Primavera J., Donaghue V. M., Zacharoulis D., Chrzan J. S., Degirolami U., Logerfo F. W., Freeman R., Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998 47 3 457 463 2-s2.0-0031939017 10.2337/diabetes.47.3.457 (Pubitemid 28104210)
109. Wadham C., Parker A., Wang L., Xia P., High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 2007 56 11 2715 2721 2-s2.0-35748983833 10.2337/db06-1294 (Pubitemid 350044914)
110. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
111. Creager M. A., Lüscher T. F., Cosentino F., Beckman J. A., Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003 108 12 1527 1532 2-s2.0-0141615827 10.1161/01.CIR.0000091257.27563.32 (Pubitemid 37176462)
112. Alp N. J., Channon K. M., keith.channon@cardiov.ox.ac.uk Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 3 413 420 10.1161/01.ATV.0000110785.96039.f6 (Pubitemid 38326132)
113. Cai S., Khoo J., Mussa S., Alp N. J., Channon K. M., Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 2005 48 9 1933 1940 2-s2.0-24944458112 10.1007/s00125-005-1857-5 (Pubitemid 41317851)
114. McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R., Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992 35 8 771 776 2-s2.0-0026684462
115. Wang Y., Wei X., Xiao X., Hui R., Card J. W., Carey M. A., Dao W. W., Zeldin D. C., Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Journal of Pharmacology and Experimental Therapeutics 2005 314 2 522 532 2-s2.0-22944448688 10.1124/jpet.105.083477 (Pubitemid 41043832)
116. Shankar R. R., Wu Y., Shen H. Q., Zhu J. S., Baron A. D., Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000 49 5 684 687 2-s2.0-0013054309 (Pubitemid 30339980)
117. Montagnani M., Chen H., Barr V. A., Quon M. J., Insulin-stimulated activation of enos is independent of ca2+ but requires phosphorylation by akt at ser(1179). The Journal of Biological Chemistry 2001 276 32 30392 30398 2-s2.0-0035839532 10.1074/jbc.M103702200
118. Chen J.-X., Jian-xiong.chen@vanderbilt.edu Stinnett A., Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1606 1613 10.1161/ATVBAHA.108.169235
119. Issad T., Masson E., Pagesy P., O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes and Metabolism 2010 36 6 423 435 2-s2.0-78649990012 10.1016/j.diabet.2010.09.001
120. Musicki B., Kramer M. F., Becker R. E., Burnett A. L., Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2005 102 33 11870 11875 2-s2.0-23844523172 10.1073/pnas.0502488102 (Pubitemid 41170817)
121. Lima V. V., Giachini F. R. C., Carneiro F. S., Carneiro Z. N., Fortes Z. B., Carvalho M. H. C., Webb R. C., Tostes R. C., Increased vascular O-GlcNAcylation augments reactivity to constrictor stimulivasoactive peptide symposium. Journal of the American Society of Hypertension 2008 2 6 410 417 2-s2.0-57149117122 10.1016/j.jash.2008.06.001
122. Taguchi K., Kobayashi T., Takenouchi Y., Matsumoto T., Kamata K., kamata@hoshi.ac.jp Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model. Pharmacological Research 2011 64 5 535 546 10.1016/j.phrs.2011.05.001
123. Elrod J. W., Duranski M. R., Langston W., Greer J. J. M., Tao L., Dugas
124. Sasso F. C., Torella D., Carbonara O., Ellison G. M., Torella M., Scardone M., Marra C., Nasti R., Marfella R., Cozzolino D., Indolfi C., Cotrufo M., Torella R., Salvatore T., Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. Journal of the American College of Cardiology 2005 46 5 827 834 2-s2.0-24044517938 10.1016/j.jacc.2005.06.007 (Pubitemid 41224806)
125. Chen C. A., Wang T. Y., Varadharaj S., Reyes L. A., Hemann C., Talukder M. A. H., Chen Y. R., Druhan L. J., Zweier J. L., S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010 468 7327 1115 1120 2-s2.0-78650810596 10.1038/nature09599
126. Kapadia M. R., Chow L. W., Tsihlis N. D., Ahanchi S. S., Eng J. W., Murar J., Martinez J., Popowich D. A., Jiang Q., Hrabie J. A., Saavedra J. E., Keefer L. K., Hulvat J. F., Stupp S. I., Kibbe M. R., Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. Journal of Vascular Surgery 2008 47 1 173 182 2-s2.0-37549046849 10.1016/j.jvs.2007.09.005
127. Marks D. S., Vita J. A., Folts J. D., Keaney J. F., Welch G. N., Loscalzo J., Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. The Journal of Clinical Investigation 1995 96 6 2630 2638 2-s2.0-0028787682
128. Ahanchi S. S., Varu V. N., Tsihlis N. D., Martinez J., Pearce C. G., Kapadia M. R., Jiang Q., Saavedra J. E., Keefer L. K., Hrabie J. A., Kibbe M. R., Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. American Journal of Physiology 2008 295 6 H2388 H2398 2-s2.0-57349149112 10.1152/ajpheart.00185.2008
129. Calvert J. W., Gundewar S., Jha S., Greer J. J. M., Bestermann W. H., Tian R., Lefer D. J., Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS- mediated signaling. Diabetes 2008 57 3 696 705 2-s2.0-40949087724 10.2337/db07-1098
130. Penumathsa S. V., Thirunavukkarasu M., Samuel S. M., Zhan L., Maulik G., Bagchi M., Bagchi D., Maulik N., nmaulik@neuron.uchc.edu Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochimica et Biophysica Acta 2009 1792 1 39 48 10.1016/j.bbadis.2008.10.018
131. Duplain H., Burcelin., Sartori C., Cook S., Egli M., Lepori M., Vollenweider P., Pedrazzini T., Nicod P., Thorens B., Scherrer U., Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001 104 3 342 345 2-s2.0-0035902547 (Pubitemid 32666958)
132. Waldron G. J., Ding H., Lovren F., Kubes P., Triggle C. R., Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. British Journal of Pharmacology 1999 128 3 653 658 2-s2.0-0032701197 10.1038/sj.bjp.0702858 (Pubitemid 29504756)
133. Cardillo C., Panza J. A., Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vascular Medicine 1998 3 2 138 144 2-s2.0-0031786851 (Pubitemid 28481264)
134. Bouloumié A., rbusse@em.uni.frankfurt.de Bauersachs J., Linz W., Schölkens B. A., Wiemer G., Fleming I., Busse R., Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 1997 30 4 934 941 (Pubitemid 27441125)
135. Cosentino F., Hishikawa K., Katusic Z. S., Lüscher T. F., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997 96 1 25 28 2-s2.0-0030837996 (Pubitemid 27298398)
136. Förstermann U., ulrich.forstermann@uni-mainz.de Münzel T., Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 13 1708 1714 10.1161/CIRCULATIONAHA.105.602532
137. Pannirselvam M., Verma S., Anderson T. J., Triggle C. R., Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. British Journal of Pharmacology 2002 136 2 255 263 2-s2.0-0036271495 (Pubitemid 34587672)
138. Pieper G. M., Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 1998 31 5 1047 1060 2-s2.0-0031940054 (Pubitemid 28191496)
139. Vasquez-Vivar J., Martasek P., Whitsett J., Joseph J., Kalyanaraman B., The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochemical Journal 2002 362 3 733 739 2-s2.0-0037086565 10.1042/0264-6021:3620733 (Pubitemid 34242326)
140. Raman C. S., Li H., Martásek P., Král V., Masters B. S. S., Poulos T. L., Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998 95 7 939 950 2-s2.0-0032416666 10.1016/S0092-8674(00)81718-3 (Pubitemid 29019046)
141. Channon K. M., Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends in Cardiovascular Medicine 2004 14 8 323 327 2-s2.0-13444262357 10.1016/j.tcm.2004.10.003 (Pubitemid 41110612)
142. Katusic Z. S., katusic.zvonimir@mayo.edu D'Uscio L. V., Tetrahydrobiopterin: mediator of endothelial protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 3 397 398 10.1161/01.ATV.0000121569. 76931.0b (Pubitemid 38326129)
143. Laursen J. B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B. A., Tarpey M., Fukai T., Harrison D. G., Endothelial regulation of vasomotion in ApoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001 103 9 1282 1288 2-s2.0-0035814951 (Pubitemid 32221353)
144. Cosentino F., Eto M., De Paolis P., Van der Loo B. V., Bachschmid M., Ullrich V., Kouroedov A., Gatti C. D., Joch H., Volpe M., Lüscher T. F., High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003 107 7 1017 1023 2-s2.0-0037465359 10.1161/01.CIR.0000051367.92927.07 (Pubitemid 36258726)
145. Salt I. P., Morrow V. A., Brandie F. M., Connell J. M. C., Petrie J. R., High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells. The Journal of Biological Chemistry 2003 278 21 18791 18797 2-s2.0-0038482055 10.1074/jbc.M210618200 (Pubitemid 36799260)
146. Zou M. H., Shi C., Cohen R. A., Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. The Journal of Clinical Investigation 2002 109 6 817 826 2-s2.0-0036199685 10.1172/JCI200214442 (Pubitemid 34263158)
147. Kuzkaya N., Weissmann N., Harrison D. G., Dikalov S., Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. The Journal of Biological Chemistry 2003 278 25 22546 22554 2-s2.0-0038604446 10.1074/jbc.M302227200 (Pubitemid 36830310)
148. Rodríguez-Crespo I., Gerber N. C., Ortiz De Montellano P. R., Endothelial nitric-oxide synthase: expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. The Journal of Biological Chemistry 1996 271 19 11462 11467 2-s2.0-0029889353
149. Wever R. M. F., Van Dam T., Van Rijn H. J. M., De Groot F., Rabelink T. J., Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochemical and Biophysical Research Communications 1997 237 2 340 344 10.1006/bbrc.1997.7069 (Pubitemid 27406031)
150. Cosentino F., Hürlimann D., Delli Gatti C., Chenevard R., Blau N., Alp N. J., Channon K. M., Eto M., Lerch P., Enseleit F., Ruschitzka F., Volpe M., Lüscher T. F., Noll G., georg.noll@usz.ch Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart 2008 94 4 487 492 10.1136/hrt.2007.122184 (Pubitemid 351441407)
151. Heitzer T., Brockhoff C., Mayer B., Warnholtz A., Mollnau H., Henne S., Meinertz T., Münzel T., Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circulation Research 2000 86 2 E36 E41 2-s2.0-0034602878
152. Pannirselvam M., Simon V., Verma S., Anderson T., Triggle C. R., Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. British Journal of Pharmacology 2003 140 4 701 706 2-s2.0-0242409173 10.1038/sj.bjp.0705476 (Pubitemid 37386434)
153. Pieper G. M., Siebeneich W., Moore-Milton G., Roza A. M., Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia 1997 40 8 910 915 2-s2.0-0030801087 10.1007/s001250050767 (Pubitemid 27316571)
154. Pieper G. M., Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. Journal of Cardiovascular Pharmacology 1997 29 1 8 15 10.1097/00005344- 199701000-00002 (Pubitemid 27045168)
155. Cai S., Khoo J., Channon K. M., Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovascular Research 2005 65 4 823 831 2-s2.0-13844281183 10.1016/j.cardiores.2004.10.040 (Pubitemid 40249727)
156. Stuehr D. J., Griffith O. W., Mammalian nitric oxide synthases. Advances in Enzymology and Related Areas of Molecular Biology 1992 65 287 346 2-s2.0-0026456161
157. Harada T., Kagamiyama H., Hatakeyama K., Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity. Science 1993 260 5113 1507 1510 2-s2.0-0027251094 (Pubitemid 23273265)
158. Alp N. J., Mussa S., Khoo J., Cai S., Guzik T., Jefferson A., Goh N., Rockett K. A., Channon K. M., Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. The Journal of Clinical Investigation 2003 112 5 725 735 2-s2.0-0141612000 10.1172/JCI200317786 (Pubitemid 38057713)
159. Meininger C. J., Cai S., Parker J. L., Channon K. M., Kelly K. A., Becker E. J., Wood M. K., Wade L. A., Wu G., GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. The FASEB Journal 2004 18 15 1900 1902 2-s2.0-10044245949 10.1096/fj.04-1702fje (Pubitemid 39602277)
160. Ishii M., Shimizu S., Nagai T., Shiota K., Kiuchi Y., Yamamoto T., Stimulation of tetrahydrobiopterin synthesis induced by insulin: possible involvement of phosphatidylinositol 3-kinase. International Journal of Biochemistry and Cell Biology 2001 33 1 65 73 2-s2.0-0035129395 10.1016/S1357-2725(00)00070-4 (Pubitemid 32146468)
161. Verma S., Arikawa E., Yao L., Laher I., McNeill J. H., Preliminary report: insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis. Metabolism 1998 47 9 1037 1039 2-s2.0-0032160994 10.1016/S0026- 0495(98)90273-6 (Pubitemid 28428004)
162. Viveros O. H., Lee C. L., Abou-Donia M. M., Biopterin cofactor biosynthesis: independent regulation of GTP cyclohyrolase in adrenal medulla and cortex. Science 1981 213 4505 349 350 (Pubitemid 11012149)
163. Cosentino F., Barker J. E., Brand M. P., Heales S. J., Werner E. R., Tippins J. R., West N., Channon K. M., Volpe M., Lüscher T. F., cardiotfl@gmx.ch Reactive oxygen species mediate endothelium-dependent relaxations in Tetrahydrobiopterin-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 4 496 502 (Pubitemid 32323379)
164. Mitchell B. M., Dorrance A. M., Webb R. C., GTP cyclohydrolase 1 downregulation contributes to glucocorticoid hypertension in rats. Hypertension 2003 41 3 669 674 2-s2.0-0037338639 10.1161/01.HYP.0000051889.62249.5D (Pubitemid 36314572)
165. Zheng J. S., Yang X. Q., Lookingland K. J., Fink G. D., Hesslinger C., Kapatos G., Kovesdi I., Chen A. F., Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 2003 108 10 1238 1245 2-s2.0-0041915626 10.1161/01.CIR.0000089082.40285.C3 (Pubitemid 37099994)
166. Okumura M., Masada M., Yoshida Y., Shintaku H., Hosoi M., Okada N., Konishi Y., Morikawa T., Miura K., Imanishi M., Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats. Kidney International 2006 70 3 471 476 2-s2.0-33746540481 10.1038/sj.ki.5000431 (Pubitemid 44141573)
167. Wenzel P., Daiber A., Oelze M., Brandt M., Closs E., Xu J., Thum T., Bauersachs J., Ertl G., Zou M.-H., Förstermann U., Münzel T., tmuenzel@uni-mainz.de Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008 198 1 65 76 10.1016/j.atherosclerosis.2007.10.003
168. Xu J., Wu Y., Song P., Zhang M., Wang S., Zou M. H., Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007 116 8 944 953 2-s2.0-34548134851 10.1161/CIRCULATIONAHA.106.684795 (Pubitemid 47300919)
169. Cosentino F., Lüscher T. F., Endothelial dysfunction in diabetes mellitus. Journal of Cardiovascular Pharmacology 1998 32 supplement 3 S54 S61 (Pubitemid 29019754)
170. Berkowitz D. E., White R., Li D., Minhas K. M., Cernetich A., Kim S., Burke S., Shoukas A. A., Nyhan D., Champion H. C., Hare J. M., Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Circulation 2003 108 16 2000 2006 2-s2.0-0142023863 10.1161/01.CIR.0000092948.04444.C7 (Pubitemid 37296546)
171. Kaesemeyer W. H., Ogonowski A. A., Jin L., Caldwell R. B., Caldwell R. W., Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. British Journal of Pharmacology 2000 131 5 1019 1023 2-s2.0-0033708990
172. Bivalacqua T. J., Hellstrom W. J. G., Kadowitz P. J., Champion H. C., Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochemical and Biophysical Research Communications 2001 283 4 923 927 10.1006/bbrc.2001.4874 (Pubitemid 32924668)
173. Zhang C., Hein T. W., Wang W., Miller M. W., Fossum T. W., McDonald M. M., Humphrey J. D., Kuo L., Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004 44 6 935 943 2-s2.0-9644282852 10.1161/01.HYP.0000146907.82869.f2 (Pubitemid 39577425)
174. Jiang M., Jia L., Jiang W., Hu X., Zhou H., Gao X., Lu Z., Zhang Z., zhzhang@fudan.edu.cn Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochemical and Biophysical Research Communications 2003 309 1 196 200 10.1016/S0006-291X(03)01559-6 (Pubitemid 36999777)
175. Zhang C., Hein T. W., Wang W., Chang C. I., Kuo L., Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. The FASEB Journal 2001 15 7 1264 1266 2-s2.0-0035347173
176. Chicoine L. G., Paffett M. L., Young T. L., Nelin L. D., Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. American Journal of Physiology 2004 287 1 L60 L68 2-s2.0-2942741190 10.1152/ajplung.00194.2003 (Pubitemid 38787651)
177. Li H., Meininger C. J., Hawker Jr. J. R., Haynes T. E., Kepka-Lenhart D., Mistry S. K., Morris S. M. Jr., Wu G., g-wu@tamu.edu Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. American Journal of Physiology 2001 280 1 E75 E82
178. Bond J. S., Failla M. L., Unger D. F., Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. The Journal of Biological Chemistry 1983 258 13 8004 8009 2-s2.0-0020967919 (Pubitemid 13075266)
179. Spolarics Z., Bond J. S., Comparison of biochemical properties of liver arginase from streptozocin-induced diabetic and control mice. Archives of Biochemistry and Biophysics 1989 274 2 426 433 2-s2.0-0024439993 (Pubitemid 19261137)
180. Hagenfeldt L., Dahlquist G., Persson B., Plasma amino acids in relation to metabolic control in insulin-dependent diabetic children. Acta Paediatrica Scandinavica 1989 78 2 278 282 (Pubitemid 19079578)
181. Pieper G. M., Dondlinger L. A., Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. Journal of Pharmacology and Experimental Therapeutics 1997 283 2 684 691 2-s2.0-0030779576 (Pubitemid 27514627)
182. Kämpfer H., Pfeilschifter J., Frank S., S.Frank@em.uni-frankfurt.de Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair. Journal of Investigative Dermatology 2003 121 6 1544 1551 10.1046/j.1523-1747.2003.12610.x (Pubitemid 38005511)
183. Durante W., durantew@health.missouri.edu Johnson F. K., Johnson R. A., Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clinical and Experimental Pharmacology and Physiology 2007 34 9 906 911 10.1111/j.1440-1681.2007.04638.x (Pubitemid 47083958)
184. Romero M. J., Platt D. H., Tawfik H. E., Labazi M., El-Remessy A. B., Bartoli M., Caldwell R. B., Caldwell R. W., Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circulation Research 2008 102 1 95 102 2-s2.0-37849019273 10.1161/CIRCRESAHA.107.155028
185. Grönros J., julia.gronros@ki.se Jung C., Lundberg J. O., Cerrato R., Östenson C., Pernow J., Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. American Journal of Physiology 2011 300 4 H1174 H1181 10.1152/ajpheart.00560.2010
186. De Vriese A. S., Verbeuren T. J., Van De Voorde J., Lameire N. H., Vanhoutte P. M., Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000 130 5 963 974 2-s2.0-0033920419 (Pubitemid 30453529)
187. Kaneda H., Taguchi J., Kuwada Y., Hangaishi M., Aizawa T., Yamakado M., Ogasawara K., Aizawa T., Ohno M., Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. Circulation Journal 2006 70 4 409 413 2-s2.0-33645354062 10.1253/circj.70.409
188. Miller F. J. Jr., Dellsperger K. C., Gutterman D. D., Pharmacologic activation of the human coronary microcirculation in vitro: endothelium- dependent dilation and differential responses to acetylcholine. Cardiovascular Research 1998 38 3 744 750 2-s2.0-0032103815 10.1016/S0008-6363(98)00035-2 (Pubitemid 28319884)
189. Beleznai T., Feher A., Spielvogel D., Lansman S. L., Bagi Z., zsolt-bagi@nymc.edu Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. American Journal of Physiology 2011 300 3 H777 H783 10.1152/ajpheart.00831.2010
190. Hoeldtke R. D., Bryner K. D., McNeill D. R., Hobbs G. R., Baylis C., Peroxynitrite versus nitric oxide in early diabetes. American Journal of Hypertension 2003 16 9 761 766 2-s2.0-0141840811 10.1016/S0895-7061(03)00976-2 (Pubitemid 37175992)
191. Kossenjans W., Eis A., Sahay R., Brockman D., Myatt L., Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. American Journal of Physiology 2000 278 4 H1311 H1319 2-s2.0-0034016067 (Pubitemid 30235511)
192. Pacher P., Liaudet L., Soriano F. G., Mabley J. G., Szabó É., Szabó C., The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 2002 51 2 514 521 2-s2.0-0036064154 (Pubitemid 34764811)
193. Pacher P., Szabo C., Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. American Journal of Pathology 2008 173 1 2 13 2-s2.0-46749118458 10.2353/ajpath.2008.080019 (Pubitemid 351947950)
194. Thuraisingham R. C., Nott C. A., Dodd S. M., Yaqoob M. M., Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney International 2000 57 5 1968 1972 2-s2.0-0034078563 10.1046/j.1523-1755. 2000.00046.x (Pubitemid 30252288)
195. Szabó C., Ischiropoulos H., Radi R., Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews Drug Discovery 2007 6 8 662 680 10.1038/nrd2222 (Pubitemid 47207751)
196. Chen W., Druhan L. J., Chen C. A., Hemann C., Chen Y. R., Berka V., Tsai A. L., Zweier J. L., Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition. Biochemistry 2010 49 14 3129 3137 2-s2.0-77950632502 10.1021/bi9016632
197. Milstien S., milstien@codon.nih.gov Katusic Z., Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochemical and Biophysical Research Communications 1999 263 3 681 684 10.1006/bbrc.1999.1422 (Pubitemid 29490686)
198. Ehrlich W., Huser H., Kroger H., Inhibition of the induction of collagenase by interleukin-1 β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide. Rheumatology International 1995 15 4 171 172 2-s2.0-0029557414 10.1007/BF00301776 (Pubitemid 26023729)
199. Zingarelli B., Salzman A. L., Szabó C., Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circulation Research 1998 83 1 85 94 2-s2.0-0032514225 (Pubitemid 28322102)
200. Cooke C. L. M., Davidge S. T., Peroxynitrite increases iNOS through NF- κ B and decreases prostacyclin synthase in endothelial cells. American Journal of Physiology 2002 282 2 C395 C402 2-s2.0-0036080603 (Pubitemid 34663199)
201. Nagai R., Unno Y., Hayashi M. C., Masuda S., Hayase F., Kinae N., Horiuchi S., Peroxynitrite induces formation of N ε -(carboxymethyl)lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002 51 9 2833 2839 2-s2.0-0036724199 (Pubitemid 34970938)
202. Klatt P., Pineda Molina E., Pérez-Sala D., Lamas S., Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochemical Journal 2000 349 2 567 578 2-s2.0-0034662178 10.1042/0264-6021: 3490567 (Pubitemid 30465792)
203. Casagrande S., Bonetto V., Fratelli M., Gianazza E., Eberini I., Massignan T., Salmona M., Chang G., Holmgren A., Ghezzi P., Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proceedings of the National Academy of Sciences of the United States of America 2002 99 15 9745 9749 2-s2.0-18444369324 10.1073/pnas.152168599 (Pubitemid 34831118)
204. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., Bonetto V., Mengozzi M., Duffieux F., Miclet E., Bachi A., Vandekerckhove J., Gianazza E., Ghezzi P., Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 2002 99 6 3505 3510 2-s2.0-18344390036 10.1073/pnas.052592699 (Pubitemid 34252138)
205. Adachi T., Weisbrod R. M., Pimentel D. R., Ying J., Sharov V. S., Schöneich C., Cohen R. A., S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nature Medicine 2004 10 11 1200 1207 2-s2.0-9144266981 10.1038/nm1119 (Pubitemid 39540436)
206. Cappiello M., Amodeo P., Mendez B. L., Scaloni A., Vilardo P. G., Cecconi I., Monte M. D., Banditelli S., Talamo F., Micheli V., Giblin F. J., Corso A. D., Mura U., Modulation of aldose reductase activity through S-thiolation by physiological thiols. Chemico-Biological Interactions 2001 130-132 597 608 2-s2.0-0035969903 10.1016/S0009-2797(00)00286-6 (Pubitemid 32295847)
207. Li S., Richard Whorton A., awho@duke.edu Regulation of protein tyrosine phosphatase 1B in intact cells by S-nitrosothiols. Archives of Biochemistry and Biophysics 2003 410 2 269 279 10.1016/S0003-9861(02)00696-3 (Pubitemid 36259827)
208. Giustarini D., Rossi R., Milzani A., Colombo R., Dalle-Donne I., S-glutathionylation: from redox regulation of protein functions to human diseases. Journal of Cellular and Molecular Medicine 2004 8 2 201 212 2-s2.0-14044272119 (Pubitemid 44145509)
209. Niwa T., Naito C., Mawjood A. H. M., Imai K., Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization- mass spectrometry. Clinical Chemistry 2000 46 1 82 88 2-s2.0-0033952927 (Pubitemid 30090963)
210. Maritim A. C., Sanders R. A., Watkins J. B., Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003 17 1 24 38 2-s2.0-0037253073 10.1002/jbt.10058 (Pubitemid 36410972)
211. Vita J. A., Frei B., Holbrook M., Gokce N., Leaf C., Keaney J. F., L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. The Journal of Clinical Investigation 1998 101 6 1408 1414 2-s2.0-0032521146 (Pubitemid 28145258)
212. Mieyal J. J., Gallogly M. M., Qanungo S., Sabens E. A., Shelton M. D., Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxidants and Redox Signaling 2008 10 11 1941 1988 2-s2.0-51349088530 10.1089/ars.2008.2089
213. Srivastava S. K., Ramana K. V., Bhatnagar A., Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews 2005 26 3 380 392 2-s2.0-18844369302 10.1210/er.2004-0028 (Pubitemid 40691299)
214. Petrash J. M., Harter T. M., Devine C. S., Olins P. O., Bhatnagar A., Liu S., Srivastava S. K., Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303. The Journal of Biological Chemistry 1992 267 34 24833 24840 2-s2.0-0026496902
215. Cappiello M., Voltarelli M., Giannessi M., Cecconi I., Camici G., Manao G., Del Corso A., Mura U., Glutathione dependent modification of bovine lens aldose reductase. Experimental Eye Research 1994 58 4 491 501 2-s2.0-0028227366 10.1006/exer.1994.1042 (Pubitemid 24171659)
216. Chandra A., Srivastava S., Petrash J. M., Bhatnagar A., Srivastava S. K., ssrivast@utmb.edu Active site modification of aldose reductase by nitric oxide donors. Biochimica et Biophysica Acta 1997 1341 2 217 222 10.1016/S0167-4838(97) 00084-8 (Pubitemid 27451938)
217. Shelton M. D., Kern T. S., Mieyal J. J., JJM5@case.edu Glutaredoxin regulates nuclear factor κ -B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. The Journal of Biological Chemistry 2007 282 17 12467 12474 10.1074/jbc.M610863200 (Pubitemid 47100623)
218. Cohen R. A., Weisbrod R. M., Gericke M., Yaghoubi M., Bierl C., Bolotina V. M., Mechanism of nitric oxide-induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx. Circulation Research 1999 84 2 210 219 2-s2.0-0033524720 (Pubitemid 29070117)
219. Tong X., Ying J., Pimentel D. R., Trucillo M., Adachi T., Cohen R. A., High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. Journal of Molecular and Cellular Cardiology 2008 44 2 361 369 2-s2.0-39149126992 10.1016/j.yjmcc.2007.10.022
220. Duncan E., Ezzat V., Kearney M., Insulin and endothelial function: physiological environment defines effect on atherosclerotic risk. Current Diabetes Reviews 2006 2 1 51 60 2-s2.0-33746114908 10.2174/157339906775473590 (Pubitemid 44082950)
221. Clavreul N., Bachschmid M. M., Hou X., Shi C., Idrizovic A., Ido Y., Pimentel D., Cohen R. A., racohen@bu.edu S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2454 2461 10.1161/01.ATV.0000242791.28953.4c (Pubitemid 44607465)
222. Song P., Wu Y., Xu J., Xie Z., Dong Y., Zhang M., Zou M. H., Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation 2007 116 14 1585 1595 2-s2.0-34848892187 10.1161/CIRCULATIONAHA.107.716498 (Pubitemid 47511422)
223. Wang J., Pan S., ShiPan@urmc.rochester.edu Berk B. C., Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 6 1283 1288 10.1161/ATVBAHA.107.144659 (Pubitemid 46809416)
224. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., Kondo T., Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of akt. The Journal of Biological Chemistry 2003 278 50 50226 50233 2-s2.0-0346749513 10.1074/jbc.M310171200 (Pubitemid 37548863)
225. Koya D., King G. L., Protein kinase C activation and the development of diabetic complications. Diabetes 1998 47 6 859 866 2-s2.0-0031860340 10.2337/diabetes.47.6.859 (Pubitemid 28255657)
226. Chu F., Ward N. E., O'Brian C. A., Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine. Carcinogenesis 2001 22 8 1221 1229 2-s2.0-0034903753 (Pubitemid 32737339)
227. Clarke M., Margaret.Clarke@heartofengland.nhs.uk Dodson P. M., PKC inhibition and diabetic microvascular complications. Best Practice and Research 2007 21 4 573 586 10.1016/j.beem.2007.09.007 (Pubitemid 350177570)
228. Huang A., Xiao H., Samii J. M., Vita J. A., Keaney J. F., Contrasting effects of thiol-modulating agents on endothelial NO bioactivity. American Journal of Physiology 2001 281 2 C719 C725 2-s2.0-0034891330
229. Martina V., Bruno G. A., Zumpano E., Origlia C., Quaranta L., Pescarmona G. P., Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. Journal of Endocrinological Investigation 2001 24 1 37 41 (Pubitemid 32166327)
230. Ghigo D., Alessio P., Foco A., Bussolino F., Costamagna C., Heller R., Garbarino G., Pescarmona G. P., Bosia A., Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. The American Journal of Physiology 1993 265 3 C728 C732 2-s2.0-0027660945
231. Zhang X., Li H., Jin H., Ebin Z., Brodsky S., Goligorsky M. S., Effects of homocysteine on endothelial nitric oxide production. American Journal of Physiology 2000 279 4 F671 F678 2-s2.0-0033679320
232. Mukai N., Akahori T., Komaki M., Li Q., Kanayasu-Toyoda T., Ishii-Watabe A., Kobayashi A., Yamaguchi T., Abe M., Amagasa T., Morita I., A comparison of the tube forming potentials of early and late endothelial progenitor cells. Experimental Cell Research 2008 314 3 430 440 2-s2.0-38349045409 10.1016/j.yexcr.2007.11.016
233. Fadini G. P., Baesso I., Albiero M., Sartore S., Agostini C., Avogaro A., Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008 197 2 496 503 2-s2.0-40949152378 10.1016/j.atherosclerosis.2007.12.039
234. Hristov M., mhristov@klp.med.uni-muenchen.de Erl W., Weber P. C., Endothelial progenitor cells: mobilization, differentiation, and homing. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1185 1189 10.1161/01.ATV.0000073832.49290.B5 (Pubitemid 36871271)
235. Urbich C., Dimmeler S., Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research 2004 95 4 343 353 2-s2.0-4143052506 10.1161/01.RES.0000137877.89448.78 (Pubitemid 39100452)
236. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A. M., Dimmeler S., Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research 2001 89 1 E1 E7 2-s2.0-17644433975
237. Schatteman G. C., Hanlon H. D., Jiao C., Dodds S. G., Christy B. A., Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. The Journal of Clinical Investigation 2000 106 4 571 578 2-s2.0-0033857389 (Pubitemid 30666390)
238. Ding H., Triggle C. R., Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vascular Health and Risk Management 2005 1 1 55 71 2-s2.0-21644435395 10.2147/vhrm.1.1.55.58939
239. Tamarat R., Silvestre J. S., Le Ricousse-Roussanne S., Barateau V., Lecomte-Raclet L., Clergue M., Duriez M., Tobelem G., Lévy B. I., Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. American Journal of Pathology 2004 164 2 457 466 2-s2.0-1542379710 (Pubitemid 38364662)
240. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M., Nickenig G., Circulating endothelial progenitor cells and cardiovascular outcomes. The New England Journal of Medicine 2005 353 10 999 1007 2-s2.0-24344442873 10.1056/NEJMoa043814 (Pubitemid 41262334)
241. Schmidt-Lucke C., Rössig L., Fichtlscherer S., Vasa M., Britten M., Kämper U., Dimmeler S., dimmeler@em.uni-frankfurt.de Zeiher A. M., zeiher@em.uni-frankfurt.de Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 111 22 2981 2987 10.1161/CIRCULATIONAHA.104.504340 (Pubitemid 40814192)
242. Imanishi T., t-imani@wakayama-med.ac.jp Hano T., Sawamura T., Nishio I., Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clinical and Experimental Pharmacology and Physiology 2004 31 7 407 413 10.1111/j.1440-1681.2004.04022.x (Pubitemid 39044118)
243. Kielczewski J. L., Jarajapu Y. P. R., McFarland E. L., Cai J., Afzal A., Calzi S. L., Chang K. H., Lydic T., Shaw L. C., Busik J., Hughes J., Cardounel A. J., Wilson K., Lyons T. J., Boulton M. E., Mames R. N., Chan-Ling T., Grant M. B., Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circulation Research 2009 105 9 897 905 2-s2.0-70350719504 10.1161/CIRCRESAHA.109.199059
244. Feng X. M., Zhou B., Chen Z., Ren Q., Shi H. L., Sawamura T., Zhong C. H., Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. Journal of Lipid Research 2006 47 6 1227 1237 2-s2.0-33744807726 10.1194/jlr.M500507-JLR200 (Pubitemid 43830715)
245. Reinhard H., Karl Jacobsen P., Lajer M., Pedersen N., Billestrup N., Mandrup-Poulsen T., Parving H. H., Rossing P., Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologia 2010 53 10 2129 2133 2-s2.0-77958043929 10.1007/s00125-010-1843-4
246. Sorrentino S. A., Bahlmann F. H., Besler C., Müller M., Schulz S., Kirchhoff N., Doerries C., Horváth T., Limbourg A., Limbourg F., Fliser D., Haller H., Drexler H., Landmesser U., Landmesser.Ulf@MH-Hannover.de Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor- γ agonist rosiglitazone. Circulation 2007 116 2 163 173 10.1161/CIRCULATIONAHA.106.684381 (Pubitemid 47057522)
247. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J. D., Tsikas D., Ertl G., Bauersachs J., Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 3 666 674 2-s2.0-33847346061 10.2337/db06-0699 (Pubitemid 46348461)
248. Rehman J., Li J., Orschell C. M., March K. L., Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003 107 8 1164 1169 2-s2.0-0037418213 10.1161/01.CIR.0000058702.69484.A0 (Pubitemid 36297209)
249. Chen Y. H., Lin S. J., Lin F. Y., Wu T. C., Tsao C. R., Huang P. H., Liu P. L., Chen Y. L., Chen J. W., High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007 56 6 1559 1568 2-s2.0-34249696575 10.2337/db06-1103 (Pubitemid 46842612)
250. Ii M., Takenaka H., Asai J., Ibusuki K., Mizukami Y., Maruyama K., Yoon Y. S., Wecker A., Luedemann C., Eaton E., Silver M., Thorne T., Losordo D. W., Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circulation Research 2006 98 5 697 704 2-s2.0-33645303253 10.1161/01.RES.0000209948.50943.ea
251. Kränkel N., Adams V., Linke A., Gielen S., Erbs S., Lenk K., Schuler G., Hambrecht R., hamr@medizin.uni-leipzig.de Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 4 698 703 10.1161/01.ATV.0000156401.04325.8f (Pubitemid 40463856)
252. Hamano K., Nishida M., Hirata K., Mikamo A., Li T. S., Harada M., Miura T., Matsuzaki M., Esato K., Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart diseaseclinical trial and preliminary results. Japanese Circulation Journal 2001 65 9 845 847 2-s2.0-0034841919 10.1253/jcj.65.845 (Pubitemid 32845720)
253. Strauer B. E., Brehm M., Zeus T., Köstering M., Hernandez A., Sorg R. V., Kögler G., Wernet P., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002 106 15 1913 1918 10.1161/01.CIR.0000034046.87607.1C (Pubitemid 35176294)
254. Wang X.-R., Zhang M.-W., Chen D.-D., Zhang Y., Chen A. F., chena5@upmc.edu AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes. American Journal of Physiology 2011 300 6 E1135 E1145 10.1152/ajpendo.00001.2011
255. Thom S. R., Fisher D., Zhang J., Bhopale V. M., Ohnishi S. T., Kotake Y., Ohnishi T., Buerk D. G., Stimulation of perivascular nitric oxide synthesis by oxygen. American Journal of Physiology 2003 284 4 H1230 H1239 2-s2.0-0037379061 (Pubitemid 36348586)
256. Goldstein L. J., Gallagher K. A., Bauer S. M., Bauer R. J., Baireddy V., Liu Z. J., Buerk D. G., Thom S. R., Velazquez O. C., Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 2006 24 10 2309 2318 2-s2.0-33749535896 10.1634/stemcells.2006-0010 (Pubitemid 44527485)
257. Gallagher K. A., Liu Z. J., Xiao M., Chen H., Goldstein L. J., Buerk D. G., Nedeau A., Thom S. R., Velazquez O. C., Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 α The Journal of Clinical Investigation 2007 117 5 1249 1259 2-s2.0-34248213008 10.1172/JCI29710 (Pubitemid 46718413)
258. Kuhlmann C. R. W., Schaefer C. A., Reinhold L., Tillmanns H., Erdogan A., Signalling mechanisms of SDF-induced endothelial cell proliferation and migration. Biochemical and Biophysical Research Communications 2005 335 4 1107 1114 2-s2.0-24044527479 10.1016/j.bbrc.2005.08.006 (Pubitemid 41215533)
259. Tan Y., Shao H., Eton D., Yang Z., Alonso-Diaz L., Zhang H., Schulick A., Livingstone A. S., Yu H., Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovascular Research 2007 73 4 823 832 2-s2.0-33846886138 10.1016/j.cardiores.2006.12.015 (Pubitemid 46227354)
260. Desouza C. V., cdesouza@unmc.edu Hamel F. G., Bidasee K., O'Connell K., Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 2011 60 4 1286 1294 10.2337/db10-0875
261. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 5302 964 967 2-s2.0-0031019745 10.1126/science.275.5302.964 (Pubitemid 27087709)
262. Schatteman G. C., Dunnwald M., Jiao C., Biology of bone marrow-derived endothelial cell precursors. American Journal of Physiology 2007 292 1 H1 H18 2-s2.0-33846195498 10.1152/ajpheart.00662.2006 (Pubitemid 46105160)
263. Spring H., Schüler T., Arnold B., Hämmerling G. J., Ganss R., r.ganss@dkfz.de Chemokines direct endothelial progenitors into tumor neovessels. Proceedings of the National Academy of Sciences of the United States of America 2005 102 50 18111 18116 10.1073/pnas.0507158102 (Pubitemid 41798510)
264. Brunner S., simon.brunner@wienkav.at Schernthaner G.-H., Satler M., Elhenicky M., Hoellerl F., Schmid-Kubista K. E., Zeiler F., Binder S., Schernthaner G., Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Investigative Ophthalmology and Visual Science 2009 50 1 392 398 10.1167/iovs.08-1748
265. Kusuyama T., Omura T., Nishiya D., Enomoto S., Matsumoto R., Takeuchi K., Yoshikawa J., Yoshiyama M., Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. Journal of Pharmacological Sciences 2006 102 1 96 102 2-s2.0-33748969496 10.1254/jphs.FP0060256 (Pubitemid 44440972)
266. Lee I. G., Chae S. L., Kim J. C., Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye 2006 20 5 546 552 2-s2.0-33646419036 10.1038/sj.eye.6701920 (Pubitemid 43674990)
267. Calzi S. L., Neu M. B., Shaw L. C., Kielczewski J. L., Moldovan N. I., Grant M. B., EPCs and pathological angiogenesis: when good cells go bad. Microvascular Research 2010 79 3 207 216 2-s2.0-77952090934 10.1016/j.mvr.2010. 02.011
268. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N. R., Crystal R. G., Moore M. A. S., Hajjar K. A., Manova K., Benezra R., Rafii S., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine 2001 7 11 1194 1201 2-s2.0-0035160312 10.1038/nm1101-1194 (Pubitemid 33063774)
269. Khakoo A. Y., Finkel T., Endothelial progenitor cells. Annual Review of Medicine 2005 56 79 101 2-s2.0-14544282964 10.1146/annurev.med.56.090203.104149 (Pubitemid 40299775)
270. Kopp H. G., Ramos C. A., Rafii S., Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Current Opinion in Hematology 2006 13 3 175 181 2-s2.0-33646812605 10.1097/01.moh.0000219664.26528.da
271. Nyengaard J. R., Rasch R., The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993 36 3 189 194 2-s2.0-0027408091 (Pubitemid 23067077)
272. Babaei S., Teichert-Kuliszewska K., Monge J. C., Mohamed F., Bendeck M. P., Stewart D. J., Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circulation Research 1998 82 9 1007 1015 2-s2.0-0032543268 (Pubitemid 28225941)
273. Papapetropoulos A., Desai K. M., Rudic R. D., Mayer B., Zhang R., Ruiz-Torres M. P., García-Cardeña G., Madri J. A., Sessa W. C., Nitric oxide synthase inhibitors attenuate transforming-growth-factor- β 1-stimulated capillary organization in vitro. American Journal of Pathology 1997 150 5 1835 1844 2-s2.0-0030901666 (Pubitemid 27193829)
274. Simons M., Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? Journal of the American College of Cardiology 2005 46 5 835 837 2-s2.0-24044438290 10.1016/j.jacc.2005.06.008 (Pubitemid 41224807)
275. Takeuchi K., Takehara K., Tajima K., Kato S., Hirata T., Impaired healing of gastric lesions in streptozotocin-induced diabetic rats: effect of basic fibroblast growth factor. Journal of Pharmacology and Experimental Therapeutics 1997 281 1 200 207 2-s2.0-0030910972 (Pubitemid 27203069)
276. Wong A. L., Haroon Z. A., Werner S., Dewhirst M. W., Greenberg C. S., Peters K. G., Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circulation Research 1997 81 4 567 574 2-s2.0-0030764063 (Pubitemid 27432744)
277. Tanii M., Yonemitsu Y., Fujii T., Shikada Y., Kohno R. I., Onimaru M., Okano S., Inoue M., Hasegawa M., Onohara T., Maehara Y., Sueishi K., Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circulation Research 2006 98 1 55 62 2-s2.0-33644834384 10.1161/01.RES.0000197842.38758.45 (Pubitemid 43970203)
278. Delamaire M., Maugendre D., Moreno M., Le Goff M. C., Allannic H., Genetet B., Impaired leucocyte functions in diabetic patients. Diabetic Medicine 1997 14 1 29 34 2-s2.0-0031035272 10.1002/(SICI)1096-9136(199701)14:129::AID- DIA300>3.0.CO;2-V (Pubitemid 27019919)
279. Mowat A., Baum J., Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. The New England Journal of Medicine 1971 284 12 621 627 2-s2.0-0015239227
280. Bagdade J. D., Stewart M., Walters E., Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978 27 6 677 681 2-s2.0-0018104342 (Pubitemid 8370534)
281. Tan A. S., Ahmed N., Berridge M. V., Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor. Blood 1998 91 2 649 655 2-s2.0-0031982999 (Pubitemid 28053390)
282. Marhoffer W., Stein M., Maeser E., Federlin K., Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992 15 2 256 260 2-s2.0-0026547433
283. Katz S., Klein B., Elian I., Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 1983 6 5 479 482 (Pubitemid 13005557)
284. Yan J., Tie G., Park B., Yan Y., Nowicki P. T., Messina L. M., Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. Journal of Vascular Surgery 2009 50 6 1412 1422 2-s2.0-70649107812 10.1016/j.jvs.2009.08.007
285. Reiber G. E., Smith D. G., Vileikyte L., Lavery L. A., Boyko E. J., Boulton A. J. M., Del Aguila M., Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999 22 1 157 162 2-s2.0-0345654302 10.2337/diacare.22.1.157 (Pubitemid 29028314)
286. McNeely M. J., Boyko E. J., Ahroni J. H., Stensel V. L., Reiber G. E., Smith D. G., Pecoraro R. E., The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 1995 18 2 216 219 2-s2.0-0028938691
287. Loots M. A. M., Lamme E. N., Zeegelaar J., Mekkes J. R., Bos J. D., Middelkoop E., Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. Journal of Investigative Dermatology 1998 111 5 850 857 2-s2.0-0031738762 10.1046/j.1523-1747.1998. 00381.x (Pubitemid 28509329)
288. Tie L., Li X. J., Wang X., Channon K. M., Chen A. F., Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes. American Journal of Physiology 2009 296 6 E1423 E1429 2-s2.0-66849099663 10.1152/ajpendo.00150.2009
289. Efron D. T., Most D., Barbul A., Role of nitric oxide in wound healing. Current Opinion in Clinical Nutrition and Metabolic Care 2000 3 3 197 204 2-s2.0-0033942546 10.1097/00075197-200005000-00006 (Pubitemid 30469074)
290. Frank S., Stallmeyer B., Kämpfer H., Kolb N., Pfeilschifter J., Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. The FASEB Journal 1999 13 14 2002 2014 2-s2.0-0032721941 (Pubitemid 29517630)
291. Galiano R. D., Tepper O. M., Pelo C. R., Bhatt K. A., Callaghan M., Bastidas N., Bunting S., Steinmetz H. G., Gurtner G. C., Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. American Journal of Pathology 2004 164 6 1935 1947 2-s2.0-2442717879 (Pubitemid 38669343)
292. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002 45 7 1011 1016 2-s2.0-0036020282 10.1007/s00125-002-0868-8 (Pubitemid 34762196)
293. Maruyama K., Asai J., Ii M., Thorne T., Losordo D. W., D'Amore P. A., Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. American Journal of Pathology 2007 170 4 1178 1191 2-s2.0-34247874642 10.2353/ajpath.2007.060018 (Pubitemid 47339326)
294. Bessman A. N., Sapico F. L., Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors. Journal of Diabetes and Its Complications 1992 6 4 258 262 2-s2.0-0026987989 10.1016/1056-8727(92)90062- P (Pubitemid 23129164)
295. Nolan C. M., Beaty H. N., Bagdade J. D., Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978 27 9 889 894 2-s2.0-0018073427 (Pubitemid 9023044)
296. Fang Y., Shen J., Yao M., Beagley K. W., Hambly B. D., Bao S., Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. British Journal of Dermatology 2010 162 3 478 486 2-s2.0-76949084796 10.1111/j.1365-2133.2009. 09528.x
297. Marston W. A., Hanft J., Norwood P., Pollak R., The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003 26 6 1701 1705 2-s2.0-0043171152 10.2337/diacare.26.6.1701 (Pubitemid 36929107)
298. Smiell J. M., Clinical safety of becaplermin (rhPDGF-BB) gel. American Journal of Surgery 1998 176 2 68S 73S 10.1016/S0002-9610(98)00174-3 (Pubitemid 28460660)
299. Duh E., Aiello L. P., Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999 48 10 1899 1906 2-s2.0-0032853603 10.2337/diabetes.48.10.1899 (Pubitemid 29458350)
300. Aiello L. P., Wong J. S., Role of vascular endothelial growth factor in diabetic vascular complications. Kidney International, Supplement 2000 58 77 S113 S119 2-s2.0-0033852483
301. Williams B., A potential role angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? Mineral and Electrolyte Metabolism 1998 24 6 400 405 2-s2.0-0032413888 10.1159/000057401 (Pubitemid 29056250)
302. Simon M., Grone H. J., Johren O., Kullmer J., Plate K. H., Risau W., Fuchs E., Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. American Journal of Physiology 1995 268 2 F240 F250 2-s2.0-0028950364
303. Schultz G. S., Grant M. B., Neovascular growth factors. Eye 1991 5, part 2 170 180
304. Lu M., Kuroki M., Amano S., Tolentino M., Keough K., Kim I., Bucala R., Adamis A. P., Advanced glycation end products increase retinal vascular endothelial growth factor expression. The Journal of Clinical Investigation 1998 101 6 1219 1224 2-s2.0-0032520871 (Pubitemid 28145237)
305. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
306. Limb G. A., Chignell A. H., Green W., LeRoy F., Dumonde D. C., Distribution of TNF α and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. British Journal of Ophthalmology 1996 80 2 168 173 (Pubitemid 26058553)
307. Adamiec-Mroczek J., Oficjalska-Myczak J., Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetesrole of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 12 1665 1670 2-s2.0-56049091016 10.1007/s00417-008-0868-6
308. Meleth A. D., Agrón E., Chan C.-C., Reed G. F., Arora K., Byrnes G., Csaky K. G., Ferris III F. L., Chew E. Y., echew@nei.nih.gov Serum inflammatory markers in diabetic retinopathy. Investigative Ophthalmology and Visual Science 2005 46 11 4295 4301 10.1167/iovs.04-1057 (Pubitemid 44264635)
309. Murugeswari P., Shukla D., Rajendran A., Kim R., Namperumalsamy P., Muthukkaruppan V., Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 2008 28 6 817 824 2-s2.0-47749107263 10.1097/IAE. 0b013e31816576d5
310. Barreiro O., Martín P., González-Amaro R., Sánchez-Madrid F., fsanchez.hlpr@salud.madrid.org Molecular cues guiding inflammatory responses. Cardiovascular Research 2010 86 2 174 182 10.1093/cvr/cvq001
311. McLeod D. S., Lefer D. J., Merges C., Lutty G. A., Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. American Journal of Pathology 1995 147 3 642 653 2-s2.0-0029162588
312. Tomanek R. J., Schatteman G. C., Angiogenesis: new insights and therapeutic potential. Anatomical Record 2000 261 3 126 135 2-s2.0-0034659306 10.1002/1097-0185(20000615)261:3126::AID-AR7>3.0.CO;2-4 (Pubitemid 30451703)
313. Avraamides C. J., Garmy-Susini B., Varner J. A., Integrins in angiogenesis and lymphangiogenesis. Nature Reviews Cancer 2008 8 8 604 617 2-s2.0-47949114114 10.1038/nrc2353
314. Casaroli Marano R. P., Preissner K. T., Vilaró S., Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Experimental Eye Research 1995 60 1 5 17 2-s2.0-0028968007 10.1016/S0014-4835(05)80079-X
315. Hammes H. P., Brownlee M., Jonczyk A., Sutter A., Preissner K. T., Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Medicine 1996 2 529 533 (Pubitemid 26151516)
316. Preissner K. T., Kanse S. M., Hammes H.-P., Integrin chatter and vascular function in diabetic retinopathy. Hormone and Metabolic Research 1997 29 12 643 645 (Pubitemid 28053661)
317. Dandona P., Aljada A., Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. Journal of Diabetes and Its Complications 2004 18 2 91 102 2-s2.0-2142710075 10.1016/S1056-8727(02)00259-3 (Pubitemid 38553939)
318. Hadi H. A. R., Al Suwaidi J. A., Endothelial dysfunction in diabetes mellitus. Vascular Health and Risk Management 2007 3 6 853 876 2-s2.0-38149142583
319. Cooke J. P., Therapeutic interventions in endothelial dysfunction: endothelium as a target organ. Clinical Cardiology 1997 20 12 II45 II51 2-s2.0-0031443413 (Pubitemid 28009563)
320. Mather K., Verma S., Anderson T., Improved endothelial function with metformin in type 2 diabetes mellitus. Journal of the American College of Cardiology 2001 37 5 1344 1350
321. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., Da Ros R., Motz E., Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002 106 10 1211 1218 2-s2.0-0037015288 10.1161/01.CIR.0000027569.76671.A8 (Pubitemid 34988638)
322. Cheetham C., Collis J., O'Driscoll G., Stanton K., Taylor R., Green D., Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. Journal of the American College of Cardiology 2000 36 5 1461 1466 2-s2.0-0034332787 10.1016/S0735-1097(00)00933-5
323. Heitzer T., Krohn K., Albers S., Meinertz T., Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000 43 11 1435 1438 2-s2.0-0033752910 10.1007/s001250051551
324. Vehkavaara S., Yki-Järvinen H., ykijarvi@cc.helsinki.fi 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 2 325 330 10.1161/01.ATV.0000113817.48983.c5 (Pubitemid 38197586)
325. Fegan P. G., Shore A. C., Mawson D., Tooke J. E., MacLeod K. M., Microvascular endothelial function in subjects with type 2 diabetes and the effect of lipid-lowering therapy. Diabetic Medicine 2005 22 12 1670 1676 2-s2.0-30044446335 10.1111/j.1464-5491.2005.01719.x (Pubitemid 43046466)
326. Littarru G. P., g.littarru@univpm.it Tiano L., Belardinelli R., Watts G. F., Coenzyme Q(10), endothelial function, and cardiovascular disease. BioFactors 2011 37 5 366 373 10.1002/biof.154
327. Nyström T., thomas.nystrom@sos.sll.se Gutniak M. K., Zhang Q., Zhang F., Holst J. J., Ahrén B., Sjöholm Å., Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. American Journal of Physiology 2004 287 6 E1209 E1215 10.1152/ajpendo.00237.2004 (Pubitemid 39491964)
328. Rask-Madsen C., Ihlemann N., Krarup T., Christiansen E., Kober L., Kistorp C. N., Torp-Pedersen C., Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001 50 712 2611 2618 2-s2.0-0035516041 (Pubitemid 33642782)
329. Diederich D., Skopec J., Diederich A., Dai F. X., Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. American Journal of Physiology 1994 266 3 H1153 H1161 2-s2.0-0028045638
330. Taylor P. D., Poston L., The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. British Journal of Pharmacology 1994 113 3 801 808 2-s2.0-0028151070 (Pubitemid 24326818)
331. Collins R., Armitage J., Parish S., Sleight P., Peto R., MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. The Lancet 2002 360 9326 23 33 2-s2.0-0037031094 10.1016/S0140-6736(02)09328-5 (Pubitemid 34756488)
332. Huang H. Y., Caballero B., Chang S., Alberg A. J., Semba R. D., Schneyer C. R., Wilson R. F., Cheng T. Y., Vassy J., Prokopowicz G., Barnes G. J., Bass E. B., The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Annals of Internal Medicine 2006 145 5 372 385 2-s2.0-33749050338 (Pubitemid 46768595)
333. Timimi F. K., Ting H. H., Haley E. A., Roddy M. A., Ganz P., Creager M. A., Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 1998 31 3 552 557 2-s2.0-0032031605 10.1016/S0735-1097(97)00536-6 (Pubitemid 28144120)
334. Koo J. R., Ni Z., Oviesi F., Vaziri N. D., Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. Clinical and Experimental Hypertension 2002 24 5 333 344 2-s2.0-0035991372 10.1081/CEH-120004795 (Pubitemid 34743397)
335. Beckman J. A., Goldfine A. B., Gordon M. B., Garrett L. A., Keaney J. F., Creager M. A., Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. American Journal of Physiology 2003 285 6 H2392 H2398 2-s2.0-0345303816 (Pubitemid 37443055)
336. Milman U., Blum S., Shapira C., Aronson D., Miller-Lotan R., Anbinder Y., Alshiek J., Bennett L., Kostenko M., Landau M., Keidar S., Levy Y., Khemlin A., Radan A., Levy A. P., alevy@tx.technion.ac.il Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 341 347 10.1161/ATVBAHA.107.153965 (Pubitemid 351161209)
337. Hundal R. S., Krssak M., Dufour S., Laurent D., Lebon V., Chandramouli V., Inzucchi S. E., Schumann W. C., Petersen K. F., Landau B. R., Shulman G. I., Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000 49 12 2063 2069 2-s2.0-0033673203
338. Kim Y. D., Park K. G., Lee Y. S., Park Y. Y., Kim D. K., Nedumaran B., Jang W. G., Cho W. J., Ha J., Lee I. K., Lee C. H., Choi H. S., Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008 57 2 306 314 2-s2.0-40749116561 10.2337/db07-0381
339. Giannarelli R., Aragona M., Coppelli A., Del Prato S., Reducing insulin resistance with metformin: the evidence today. Diabetes and Metabolism 2003 29 4 6S28 6S35 2-s2.0-18144436363 (Pubitemid 37187088)
340. Tiikkainen M., Häkkinen A.-M., Korsheninnikova E., Nyman T., Mäkimattila S., Yki-Järvinen H., ykijarvi@helsinki.fi Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004 53 8 2169 2176 10.2337/diabetes.53.8.2169 (Pubitemid 38970772)
341. De Jager J., Kooy A., Lehert P., Bets D., Wulffelé M. G., Teerlink T., Scheffer P. G., Schalkwijk C. G., Donker A. J. M., Stehouwer C. D. A., Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2005 257 1 100 109 2-s2.0-19944433033 10.1111/j.1365-2796.2004.01420.x (Pubitemid 40129131)
342. Vitale C., Mercuro G., Cornoldi A., Fini M., Volterrani M., Rosano G. M. C., Metformin improves endothelial function in patients with metabolic syndrome. Journal of Internal Medicine 2005 258 3 250 256 2-s2.0-24144488274 10.1111/j.1365-2796.2005.01531.x (Pubitemid 41243057)
343. de Aguiar L. G. K., Bahia L. R., Villela N., Laflor C., Sicuro F., Wiernsperger N., Bottino D., Bouskela E., Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes Care 2006 29 5 1083 1089 2-s2.0-33746340623 10.2337/diacare.2951083 (Pubitemid 44115248)
344. Natali A., Baldeweg S., Toschi E., Capaldo B., Barbaro D., Gastaldelli A., Yudkin J. S., Ferrannini E., Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 2004 27 6 1349 1357 2-s2.0-2542424151 10.2337/diacare.27.6.1349 (Pubitemid 38679982)
345. Turner R. C., robert.turner@drl.ox.ac.uk Cull C. A., Frighi V., Holman R. R., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999 281 21 2005 2012 10.1001/jama.281.21.2005 (Pubitemid 29254858)
346. Towler M. C., Hardie D. G., AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 2007 100 3 328 341 2-s2.0-33847080728 10.1161/01.RES.0000256090.42690.05
347. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation 2001 108 8 1167 1174 2-s2.0-0034773404 10.1172/JCI200113505 (Pubitemid 32995375)
348. Hardie D. G., Ampk and raptor: matching cell growth to energy supply. Molecular Cell 2008 30 3 263 265 2-s2.0-42949130656 10.1016/j.molcel.2008.04.012 (Pubitemid 351615323)
349. Schulz E., Anter E., Zou M. H., Keaney J. F., Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase. Circulation 2005 111 25 3473 3480 2-s2.0-21544469973 10.1161/CIRCULATIONAHA.105.546812 (Pubitemid 40923402)
350. Davis B. J., Xie Z., Viollet B., Zou M. H., Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006 55 2 496 505 2-s2.0-33644747421 10.2337/diabetes.55.02.06.db05-1064 (Pubitemid 43343281)
351. Gonon A. T., Widegren U., Bulhak A., Salehzadeh F., Persson J., Sjöquist P. O., Pernow J., Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovascular Research 2008 78 1 116 122 2-s2.0-41149094470 10.1093/cvr/cvn017 (Pubitemid 351430967)
352. Gamboa A., Abraham R., Diedrich A., Shibao C., Paranjape S. Y., Farley G., Biaggioni I., Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. Stroke 2005 36 10 2170 2175 2-s2.0-26444498539 10.1161/01.STR.0000179044.37760.9d (Pubitemid 41429240)
353. Gamboa A., Ertl A. C., Costa F., Farley G., Manier M. L., Hachey D. L., Diedrich A., Biaggioni I., Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: relevance to therapeutic preconditioning in humans. Circulation 2003 108 21 2631 2635 2-s2.0-0345707538 10.1161/01.CIR.0000101927.70100.41 (Pubitemid 37466803)
354. De La Cruz J. P., Moreno A., Muñoz M., Campos J. M. G., De La Cuesta F. S., Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. Journal of Pharmacology and Experimental Therapeutics 1997 280 1 454 459 (Pubitemid 27171434)
355. Vallon V., Osswald H., Dipyridamole prevents diabetes-induced alterations of kidney function in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 1994 349 2 217 222 2-s2.0-0027976053 (Pubitemid 24059769)
356. Picano E., Michelassi C., Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis. Cardiovascular Research 1997 33 3 666 670 2-s2.0-0031043210 10.1016/S0008-6363(96)00262-3 (Pubitemid 27092868)
357. Symons J. D., Firoozmand E., Longhurst J. C., Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise: a role for adenosine. Circulation Research 1993 73 3 503 513 2-s2.0-0027237195 (Pubitemid 23238736)
358. Farinelli S. E., Greene L. A., Friedman W. J., Neuroprotective actions of dipyridamole on cultured CNS neurons. Journal of Neuroscience 1998 18 14 5112 5123 2-s2.0-0032528153 (Pubitemid 28311929)
359. FitzGerald G. A., Drug therapy: dipyridamole. The New England Journal of Medicine 1987 316 20 1247 1257 2-s2.0-0023653097
360. Picano E., Abbracchio M. P., European stroke prevention study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation? Trends in Pharmacological Sciences 1998 19 1 14 16 2-s2.0-0031930356 10.1016/S0165-6147(97)01148-6 (Pubitemid 28094087)
361. Siesjö B. K., Agardh C. D., Bengtsson F., Free radicals and brain damage. Cerebrovascular and brain metabolism reviews 1989 1 3 165 211
362. Iuliano L., Colavita A. R., Camastra C., Bello V., Quintarelli C., Alessandroni M., Piovella F., Violi F., Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. British Journal of Pharmacology 1996 119 7 1438 1446 2-s2.0-0029803453 (Pubitemid 26402022)
363. Pedulli G. F., Lucarini M., Marchesi E., Paolucci F., Roffia S., Fiorentini D., Landi L., Medium effects on the antioxidant activity of dipyridamole. Free Radical Biology and Medicine 1999 26 3-4 295 302
364. Venkatesh P. K., Pattillo C. B., Branch B., Hood J., Thoma S., Illum S., Pardue S., Teng X., Patel R. P., Kevil C. G., Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovascular Research 2010 85 4 661 670 2-s2.0-76749112482 10.1093/cvr/cvq002
365. Iuliano L., Pedersen J. Z., Rotilio G., Ferro D., Violi F., A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole. Free Radical Biology and Medicine 1995 18 2 239 247 2-s2.0-0028896760 10.1016/0891-5849(94)E0123-Z
366. Kusmic C., kusmic@ifc.pi.cnr.it Petersen C., Picano E., Busceti C., Parenti G., Pasini F. L., Barsacchi R., Antioxidant effect of oral dipyridamole during cerebral hypoperfusion with human carotid endarterectomy. Journal of Cardiovascular Pharmacology 2000 36 2 141 145 10.1097/00005344-200000006-00001
367. García-Fuentes E., Gil-Villarino A., Zafra M. F., García-Peregrín E., garciap@ugr.es Dipyridamole prevents the coconut oil-induced hypercholesterolemia: a study on lipid plasma and lipoprotein composition. International Journal of Biochemistry and Cell Biology 2002 34 3 269 278 10.1016/S1357-2725(01)00120-0 (Pubitemid 34159142)
368. Pattillo C. B., Bir S. C., Branch B. G., Greber E., Shen X., Pardue S., Patel R. P., Kevil C. G., Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. Free Radical Biology and Medicine 2010 50 2 262 269 2-s2.0-78650020657 10.1016/j.freeradbiomed.2010.10.714
369. Araujo L. I., McFalls E. O., Lammertsma A. A., Jones T., Maseri A., Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. Journal of Nuclear Cardiology 2001 8 3 339 346 2-s2.0-0034969326 10.1067/mnc.2001.113615 (Pubitemid 32544794)
370. McConell G. K., mcconell@unimelb.edu.au Wadley G. D., Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clinical and Experimental Pharmacology and Physiology 2008 35 12 1488 1492 10.1111/j.1440-1681.2008.05038.x
371. Tousoulis D., Tsarpalis K., Cokkinos D., Stefanadis C., Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Diabetes, Obesity and Metabolism 2008 10 10 834 842 2-s2.0-52249088883 10.1111/j.1463-1326.2007.00818.x